Literature DB >> 21517798

S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.

H Trøstrup1, R Lundquist, L H Christensen, L N Jorgensen, T Karlsmark, B B Haab, M S Agren.   

Abstract

BACKGROUND: Knowledge on the underlying mechanisms for nonhealing chronic wounds is fragmentary.
OBJECTIVES: To increase our understanding of the pathogenesis, the relationship between healing ability and a large panel of proteins was studied using a specially designed wound-healing antibody-based microarray.
METHODS: Wound fluid from nondiabetic patients with nonhealing venous leg ulcers was compared with that from patients with healing open granulating acute wounds. The high-throughput method enabled simultaneous measurement of the relative levels of 48 different proteins representing major categories of wound-healing modulators.
RESULTS: Unexpectedly, several of the examined proteins, including various proinflammatory cytokines, proteinases and antiproteinases, were not significantly (P>0·001) changed in chronic wound fluid. For example, levels of matrix metalloproteinase-9 and one of its substrates type IV collagen were similar in the two groups. The wound fluid samples displayed similar degrees of fragmentation of fibronectin by Western blot analysis and the total fibronectin levels were doubled (P<0·001) in chronic compared with acute wounds. The increased fibronectin originated from α-smooth muscle actin-positive myofibroblasts and not from the circulation. S100A8/A9 was the sole protein that was reduced (P<0·001) in wound fluid from venous ulcers [median 226 μg mL(-1) (interquartile range 213-278)] compared with healing wounds [455 μg mL(-1) (382-504)], probably reflecting a difference in inflammatory cell composition.
CONCLUSION: The molecular anomalies in chronic wounds are more subtle than the current paradigm and neither excessive proteinase activity nor deficiencies of examined extracellular matrix proteins, growth factors or angiogenic/angiostatic factors appear to contribute significantly to the nonhealing state of venous leg ulcers.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21517798     DOI: 10.1111/j.1365-2133.2011.10384.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

Review 1.  Alarmins: awaiting a clinical response.

Authors:  James K Chan; Johannes Roth; Joost J Oppenheim; Kevin J Tracey; Thomas Vogl; Marc Feldmann; Nicole Horwood; Jagdeep Nanchahal
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

2.  Pseudomonas aeruginosa biofilm hampers murine central wound healing by suppression of vascular epithelial growth factor.

Authors:  Hannah Trøstrup; Christian J Lerche; Lars J Christophersen; Kim Thomsen; Peter Ø Jensen; Hans Petter Hougen; Niels Høiby; Claus Moser
Journal:  Int Wound J       Date:  2017-11-27       Impact factor: 3.315

3.  Using antibody arrays to measure protein abundance and glycosylation: considerations for optimal performance.

Authors:  Brian B Haab; Katie Partyka; Zheng Cao
Journal:  Curr Protoc Protein Sci       Date:  2013-09-24

4.  The anti-oxidative, anti-inflammatory, and protective effect of S100A8 in endotoxemic mice.

Authors:  Ying Sun; Yu Lu; Christopher G Engeland; Sara C Gordon; Herve Y Sroussi
Journal:  Mol Immunol       Date:  2012-11-03       Impact factor: 4.407

Review 5.  Neutrophil activity in chronic venous leg ulcers--a target for therapy?

Authors:  Jodi C McDaniel; Sashwati Roy; Traci A Wilgus
Journal:  Wound Repair Regen       Date:  2013-03-28       Impact factor: 3.617

Review 6.  Protease activity as a prognostic factor for wound healing in venous leg ulcers.

Authors:  Maggie J Westby; Jo C Dumville; Nikki Stubbs; Gill Norman; Jason Kf Wong; Nicky Cullum; Richard D Riley
Journal:  Cochrane Database Syst Rev       Date:  2018-09-01

7.  A Novel S100A8/A9 Induced Fingerprint of Mesenchymal Stem Cells associated with Enhanced Wound Healing.

Authors:  Abhijit Basu; Saira Munir; Medanie A Mulaw; Karmveer Singh; Diana Crisan; Anca Sindrilaru; Nicolai Treiber; Meinhard Wlaschek; Markus Huber-Lang; Florian Gebhard; Karin Scharffetter-Kochanek
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

8.  Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: hyperglycemia-suppressed TGFβ3 expression contributes to the delay of epithelial wound healing in diabetic corneas.

Authors:  Ilham Bettahi; Haijing Sun; Nan Gao; Feng Wang; Xiaofan Mi; Weiping Chen; Zuguo Liu; Fu-Shin X Yu
Journal:  Diabetes       Date:  2013-12-04       Impact factor: 9.461

Review 9.  Resolution of Inflammation: What Controls Its Onset?

Authors:  Michelle A Sugimoto; Lirlândia P Sousa; Vanessa Pinho; Mauro Perretti; Mauro M Teixeira
Journal:  Front Immunol       Date:  2016-04-26       Impact factor: 7.561

10.  Immune Modulating Topical S100A8/A9 Inhibits Growth of Pseudomonas aeruginosa and Mitigates Biofilm Infection in Chronic Wounds.

Authors:  Hannah Trøstrup; Christian Johann Lerche; Lars Christophersen; Peter Østrup Jensen; Niels Høiby; Claus Moser
Journal:  Int J Mol Sci       Date:  2017-06-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.